Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Randomized phase 1b trial of MOR103, a human antibody to GM-CSF, in multiple sclerosis.
Influence of multiple sclerosis, age and degree of disability, in the position of the contrast sensitivity curve peak.
Neuroprotective effect of melatonin in experimental optic neuritis in rats.
Increased occurrence of anti-AQP4 seropositivity and unique HLA Class II associations with neuromyelitis optica (NMO), among Muslim Arabs in Israel.
A pilot study examining functional brain activity 6 months after memory retraining in MS: the MEMREHAB trial.
Association between OSA and Severe Fatigue in Patients with Multiple Sclerosis (MS).
Myelin basic protein immunosensor for multiple sclerosis detection based upon label-free electrochemical impedance spectroscopy.
Guidelines of the Brazilian society of bone Marrow transplantation on hematopoietic stem cell transplantation as a treatment for the autoimmune diseases systemic sclerosis and multiple sclerosis.
Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab.
Prescriptive Oriented Drug Analysis of Multiple Sclerosis Disease by LC-UV in Whole Human Blood.
Novel computer vision algorithm for the reliable analysis of organelle morphology in whole cell 3D images - A pilot study for the quantitative evaluation of mitochondrial fragmentation in amyotrophic lateral sclerosis.
Expression of a Second Ecto-5'-Nucleotidase Variant Besides the Usual Protein in Symptomatic Phase of Experimental Autoimmune Encephalomyelitis.
Molecular biomarkers in cerebrospinal fluid of multiple sclerosis patients.
Acute disseminated encephalomyelitis and other inflammatory demyelinating variants.
Callosal anatomical and effective connectivity between primary motor cortices predicts visually cued bimanual temporal coordination performance.
Neuroimmunotherapies Targeting T Cells: From Pathophysiology to Therapeutic Applications.
Gene Therapy for Rare Central Nervous System Diseases Comes to Age.
Mesenchymal stem cells of dental origin - their potential for anti-inflammatory and regenerative actions in brain and gut damage.
Bayesian scalar-on-image regression with application to association between intracranial DTI and cognitive outcomes.
New data show Novartis' Gilenya® reduced brain volume loss by one third and confirm brain volume loss link with disability in MS patients
Novel therapeutic options for multiple sclerosis.
Label free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.
Cannabinoids and autoimmune diseases: A systematic review.
Neuronal autoantibodies in patients with Rasmussen's encephalitis.
Oxidative injury in multiple sclerosis cerebellar grey matter.

Pages